Bone marrow necrosis discovered in a patient with suspected thrombotic thrombocytopenic purpura

American Journal of Hematology

Volumn 90, Issue 3, 2015, Pages 264-266

  Parekh, Hiral D ^a   Reese, Jessica A ^b   Cobb, Patrick W ^c   George, James N ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c St Vincent Frontier Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CREATININE; FIBRINOGEN; HEMOGLOBIN; PREDNISONE; RITUXIMAB; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; CORTICOSTEROID; MONOCLONAL ANTIBODY;

ABDOMINAL DISCOMFORT; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BLOOD CLOTTING TEST; BLOOD EXAMINATION; BONE MARROW BIOPSY; BONE MARROW NECROSIS; CASE REPORT; COUGHING; ENZYME ACTIVITY; FATIGUE; FLOW CYTOMETRY; GENERAL PRACTITIONER; HOSPITALIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LEUKOCYTE STRUCTURE; LOW BACK PAIN; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PHYSICAL EXAMINATION; PLASMAPHERESIS; PRIORITY JOURNAL; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; VIRUS INFECTION; WALKING DIFFICULTY; BACK PAIN; BONE MARROW; DELAYED DIAGNOSIS; DIAGNOSTIC ERROR; FATALITY; NECROSIS; PATHOLOGY; PLASMA EXCHANGE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PURPURA, THROMBOTIC THROMBOCYTOPENIC; TREATMENT FAILURE;

ADRENAL CORTEX HORMONES; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BACK PAIN; BONE MARROW; DELAYED DIAGNOSIS; DIAGNOSTIC ERRORS; FATAL OUTCOME; HUMANS; MALE; MIDDLE AGED; NECROSIS; PLASMA EXCHANGE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RITUXIMAB; TREATMENT FAILURE;

EID: 84923047963     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23840     Document Type: Article

References (22)

1. George JN. How I treat patients with thrombotic thrombocytopenic purpura - 2010. Blood 2010;116:4060-4069.
2. George JN, Nester CM. Syndromes of thrombotic microangiopathy. New Eng J Med 2014;371:654-666.
3. Griffin D, Al-Nouri ZL, Muthurajah D, et al. First symptoms in patients with thrombotic thrombocytopenic purpura: What are they and when do they occur. Transfusion 2013;53:235-237.
4. George JN, Charania RS. Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia. Semin Thromb Hemost 2013;39:153-160.
5. Deford CC, Reese JA, Schwartz LH, et al. Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood 2013;122:2023-2029.
6. George JN, Chen Q, Deford CC, et al. Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency. J Clin Apheresis 2012;12:302-311.
7. Kremer Hovinga JA, Vesely SK, Terrell DR, et al. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood 2010;115:1500-1511.
8. Wu N, Liu J, Yang S, et al. Diagnostic and prognostic values of ADAMTS13 activity measured during daily plasma exchange therapy in patients with acquired TTP. Transfusion 2015;Published online June 23, 2014.
9. Shah N, Rutherford C, Matevosyan K, et al. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP). Br J Haematol 2013;163:514-519.
10. Froehlich-Zahnd R, George JN, Vesely SK, et al. Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica 2012;97:297-303.
11. George JN. Thrombotic thrombocytopenic purpura. New Eng J Med 2006;354:1927-1935.
12. Janssens AM, Offner FC, Van Hove WZ. Bone marrow necrosis. Cancer 2000;88:1769-1780.
13. Daskalakis M, Caballero M. Bone marrow necrosis in de novo AML. Blood 2014;123:2137.
14. Gonzalez N, Rios E, Martin-Noya A, et al. Thrombotic thrombocytopenic purpura and bone marrow necrosis as a complication of gastric neoplasm. Haematologica 2002;87:ECR01.
15. Bucaloiu ID, Brady J, Walker S, et al. Thrombotic thrombocytopenic purpura and extensive bone marrow necrosis secondary to metastatic signet ring cell adenocarcinoma. J Gen Intern Med 2003;18:38-38.
16. Lee JL, Lee JH, Kim MK, et al. A case of bone marrow necrosis with thrombotic thrombocytopenic purpura as a manifestation of occult colon cancer. Jpn J Clin Oncol 2004;34:476-480.
17. Otrock ZK, Taher AT, Makarem JA, et al. Thrombotic thrombocytopenic purpura and bone marrow necrosis associated with disseminated gastric cancer. Dig Dis Sci 2007;52:1589-1591.
18. Sevinc A, Kalender ME, Pehlivan Y, et al. Thrombotic thrombocytopenic purpura and bone marrow necrosis as the initial presentation of lung cancer. Clin Appl Thromb/Hemost 2007;13:449-452.
19. Adamski J, Hanna CA, Reddy VB, et al. Multiorgan failure and bone marrow necrosis in three adults with sickle cell-beta+ -thalassemia. Am J Hematol 2012;87:621-624.
20. George JN. Systemic malignancies as a cause of unexpected microangiopathic hemolytic anemia and thrombocytopenia. Oncology 2011;25:1-8.
21. Hicks CB, Redmond J, 3rd. Adult hemolytic-uremic syndrome and bone marrow necrosis. West J Med 1984;141:680-681.
22. Booth KK, Terrell DR, Vesely SK, et al. Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol 2011;86:743-751.